Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-24

Clinical Trial Update: Coagulation After Intravenous Methylprednisolone Administration

View source ↗

Summary

The document summarizes the completed clinical trial evaluating coagulation effects after intravenous methylprednisolone administration in patients with Graves'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOLU-MEDROL (Methylprednisolone sodium succinate)

Snippet

Sponsor: Piotr Miskiewicz | Conditions: Graves' Disease, Graves Ophthalmopathy | Status: COMPLETED